New Oral AntiCoagulant Use in REnal Disease and AF (NOACURE-AF) Where do we stand? An expert consensus view using the Delphi method

dc.contributor.authorConer, Ali
dc.contributor.orcID0000-0002-5711-8873en_US
dc.contributor.pubmedID34623306en_US
dc.contributor.researcherIDABD-7321-2021en_US
dc.date.accessioned2022-08-08T10:20:49Z
dc.date.available2022-08-08T10:20:49Z
dc.date.issued2021
dc.identifier.endpage596en_US
dc.identifier.issn1016-5169en_US
dc.identifier.issue7en_US
dc.identifier.scopus2-s2.0-85118286874en_US
dc.identifier.startpage596en_US
dc.identifier.urihttp://hdl.handle.net/11727/7260
dc.identifier.volume49en_US
dc.identifier.wos000707718900014en_US
dc.language.isoengen_US
dc.relation.isversionof10.5543/tkda.2021.21180en_US
dc.relation.journalTURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleNew Oral AntiCoagulant Use in REnal Disease and AF (NOACURE-AF) Where do we stand? An expert consensus view using the Delphi methoden_US
dc.typeletteren_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: